News
StockStory.org on MSN19d
ResMed’s Q1 Earnings Call: Our Top 5 Analyst QuestionsResMed’s first quarter results were met with a strong market response, reflecting in-line revenue and profit performance alongside notable margin expansion. Management credited manufacturing and ...
These stocks were in great health last financial year. The post These 5 ASX 200 healthcare shares gained the most weight in ...
What trends should we look for it we want to identify stocks that can multiply in value over the long term? One ...
ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market.
12d
Zacks Investment Research on MSNAll You Need to Know About ResMed (RMD) Rating Upgrade to BuyResMed (RMD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- ...
Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder. Skip to main content.
Shares of ResMed Inc. RMD rallied 1.11% to $258.00 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.52% to 6,204.95 and the ...
11d
Zacks.com on MSNZacks.com featured highlights Sprouts Farmers Market, Adobe, GE Aerospace and ResMedThe stocks in this week’s article are Sprouts Farmers Market SFM, Adobe ADBE, GE Aerospace GE and ResMed RMD. Scoop Up These ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results